Erectile Dysfunction Drugs Market

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

Erectile Dysfunction Drugs Market contains market size and forecasts of Erectile Dysfunction Drugs in global, including the following market information:

Global Erectile Dysfunction Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Erectile Dysfunction Drugs Market Sales, 2017-2022, 2023-2028, (M Pill)

Global top five Erectile Dysfunction Drugs companies in 2021 (%)

The global Erectile Dysfunction Drugs market was valued at 4995.6 million in 2021 and is projected to reach US$ 7384.4 million by 2028, at a CAGR of 5.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sildenafil Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Erectile Dysfunction Drugs include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma and Seoul Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erectile Dysfunction Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Erectile Dysfunction Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pill)

Global Erectile Dysfunction Drugs Market Segment Percentages, by Type, 2021 (%)

• Sildenafil
• Tadalafil
• Others

Global Erectile Dysfunction Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pill)

Global Erectile Dysfunction Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Private Clinics
• Retail Pharmacies
• E-Commerce (B2B)
• E-Commerce (B2C)

Global Erectile Dysfunction Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pill)

Global Erectile Dysfunction Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Erectile Dysfunction Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Erectile Dysfunction Drugs revenues share in global market, 2021 (%)
• Key companies Erectile Dysfunction Drugs sales in global market, 2017-2022 (Estimated), (M Pill)
• Key companies Erectile Dysfunction Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Pfizer
• Bayer
• BaiYunShan General Factory
• S.K. Chemicals
• Teva Pharma
• Dong-A ST
• Metuchen Pharma
• Seoul Pharma
• CSBIO.